ALOFISEL 5 million cells/ml, suspension for injection 4 bottles of 6 ml
Active ingredients: DARVADSTROCEL
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Suspension for injection4 bottles of 6 mlintralésionnelle
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALOFISEL 5 millions de cellules/ml, suspension injectable
- Pharmaceutical form
- suspension injectable
- Route of administration
- intralésionnelle
- Presentation description
- 4 flacon(s) en verre de 6 ml
- Marketing authorisation holder
- TAKEDA PHARMA (DANEMARK)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 13 Dec 2024
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60511177CIP75505194CIP133400955051947Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DARVADSTROCELsuspension | 5 millions de cellules · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.